Nanoparticle-based local antimicrobial drug delivery

被引:260
作者
Gao, Weiwei [1 ]
Chen, Yijie [1 ]
Zhang, Yue [1 ]
Zhang, Qiangzhe [1 ]
Zhang, Liangfang [1 ]
机构
[1] Univ Calif San Diego, Moores Canc Ctr, Dept Nanoengn, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
Nanomedicine; Nanoparticle; Bacterial infection; Antimicrobial treatment; Local delivery; RESISTANT STAPHYLOCOCCUS-AUREUS; STABILIZED LIPOSOMES; ANTIBIOTIC DELIVERY; POLYMERIC NANOPARTICLES; ANTIBACTERIAL ACTIVITY; SILVER NANOPARTICLES; TISSUE PENETRATION; TARGETED DETECTION; SKIN INFECTION; IN-VIVO;
D O I
10.1016/j.addr.2017.09.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the wide success of antibiotics in modern medicine, the treatment of bacterial infections still faces critical challenges, especially due to the rapid emergence of antibiotic resistance. As a result, local antimicrobial treatment aimed at enhancing drug concentration at the site of infection while avoiding systemic exposure is becoming increasingly attractive, as it may alleviate resistance development. Meanwhile, therapeutic nanoparticles, especially liposomes, polymeric nanoparticles, dendrimers, and inorganic nanoparticles, are gaining traction to improve the therapeutic efficacy with many applications specifically focused on local antimicrobial treatment. This review highlights topics where nanoparticle-based strategies hold significant potential to advance treatment against local bacterial infections, including (1) promoting antibiotic localization to the pathogen, (2) modulating drug-pathogen interaction against antibiotic resistance, and (3) enabling novel anti-virulence approaches for 'drug-free' antimicrobial activity. In each area, we highlight the innovative antimicrobial strategies tailored for local applications and review the progress made for the treatment of bacterial infections. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:46 / 57
页数:12
相关论文
共 149 条
[1]   Scaling of immune responses against intracellular bacterial infection [J].
Abdullah, Zeinab ;
Knolle, Percy A. .
EMBO JOURNAL, 2014, 33 (20) :2283-2294
[2]   Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections [J].
Abed, Nadia ;
Couvreur, Patrick .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (06) :485-496
[3]   Targeting virulence: can we make evolution-proof drugs? [J].
Allen, Richard C. ;
Popat, Roman ;
Diggle, Stephen P. ;
Brown, Sam P. .
NATURE REVIEWS MICROBIOLOGY, 2014, 12 (04) :300-308
[4]   A brief history of the antibiotic era: lessons learned and challenges for the future [J].
Aminov, Rustam I. .
FRONTIERS IN MICROBIOLOGY, 2010, 1
[5]   Antibiotic resistance and its cost: is it possible to reverse resistance? [J].
Andersson, Dan I. ;
Hughes, Diarmaid .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (04) :260-271
[6]   Nanoparticles in the clinic [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (01) :10-29
[7]   Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms [J].
Asner, S. A. ;
Morre, S. A. ;
Bochud, P-Y ;
Greub, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (12) :1246-1253
[8]   A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? [J].
Baietto, Lorena ;
Corcione, Silvia ;
Pacini, Giovanni ;
Di Perri, Giovanni ;
D'Avolio, Antonio ;
De Rosa, Francesco Giuseppe .
CURRENT DRUG METABOLISM, 2014, 15 (06) :581-598
[9]   ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli [J].
Banoee, Maryam ;
Seif, Sepideh ;
Nazari, Zeinab E. ;
Jafari-Fesharaki, Parisa ;
Shahverdi, Hamid R. ;
Moballegh, Ali ;
Moghaddam, Kamyar M. ;
Shahverdi, Ahmad R. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2010, 93B (02) :557-561
[10]   Productive steps toward an antimicrobial targeting virulence [J].
Barczak, Amy K. ;
Hung, Deborah T. .
CURRENT OPINION IN MICROBIOLOGY, 2009, 12 (05) :490-496